İş dünyası · 13.09.20001 dk okuma
Lilly Research Laboratories et al.; Withdrawal of Approval of 28 New Drug Applications
Yerel otomatik çeviri · Kaynağın orijinal dili
Özet
The Food and Drug Administration (FDA) is withdrawing approval of 28 new drug applications (NDA's). The holders of the applications notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.